115 related articles for article (PubMed ID: 27718184)
1. Syntheses of Human TLR8-Specific Small-Molecule Agonists.
Beesu M; Kokatla HP; David SA
Methods Mol Biol; 2017; 1494():29-44. PubMed ID: 27718184
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.
Beesu M; Caruso G; Salyer AC; Khetani KK; Sil D; Weerasinghe M; Tanji H; Ohto U; Shimizu T; David SA
J Med Chem; 2015 Oct; 58(19):7833-49. PubMed ID: 26351878
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
[TBL] [Abstract][Full Text] [Related]
4. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.
Philbin VJ; Dowling DJ; Gallington LC; Cortés G; Tan Z; Suter EE; Chi KW; Shuckett A; Stoler-Barak L; Tomai M; Miller RL; Mansfield K; Levy O
J Allergy Clin Immunol; 2012 Jul; 130(1):195-204.e9. PubMed ID: 22521247
[TBL] [Abstract][Full Text] [Related]
5. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.
Vasilakos JP; Tomai MA
Expert Rev Vaccines; 2013 Jul; 12(7):809-19. PubMed ID: 23885825
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.
Smith AJ; Li Y; Bazin HG; St-Jean JR; Larocque D; Evans JT; Baldridge JR
Vaccine; 2016 Aug; 34(36):4304-12. PubMed ID: 27402566
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.
Salunke DB; Yoo E; Shukla NM; Balakrishna R; Malladi SS; Serafin KJ; Day VW; Wang X; David SA
J Med Chem; 2012 Sep; 55(18):8137-51. PubMed ID: 22924757
[TBL] [Abstract][Full Text] [Related]
8. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.
Dowling DJ; Tan Z; Prokopowicz ZM; Palmer CD; Matthews MA; Dietsch GN; Hershberg RM; Levy O
PLoS One; 2013; 8(3):e58164. PubMed ID: 23483986
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities.
Philbin VJ; Levy O
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1485-91. PubMed ID: 18031250
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Human Toll-Like Receptor (TLR) 8-Specific Agonist and a Functional Pan-TLR Inhibitor in 2-Aminoimidazoles.
Beesu M; Caruso G; Salyer AC; Shukla NM; Khetani KK; Smith LJ; Fox LM; Tanji H; Ohto U; Shimizu T; David SA
J Med Chem; 2016 Apr; 59(7):3311-30. PubMed ID: 26966993
[TBL] [Abstract][Full Text] [Related]
11. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
12. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
14. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
15. Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines.
Hunt JR; Kleindl PA; Moulder KR; Prisinzano TE; Forrest ML
Bioorg Med Chem Lett; 2020 Jan; 30(2):126788. PubMed ID: 31784317
[TBL] [Abstract][Full Text] [Related]
16. Identification of High-Potency Human TLR8 and Dual TLR7/TLR8 Agonists in Pyrimidine-2,4-diamines.
Beesu M; Salyer AC; Brush MJ; Trautman KL; Hill JK; David SA
J Med Chem; 2017 Mar; 60(5):2084-2098. PubMed ID: 28146629
[TBL] [Abstract][Full Text] [Related]
17. Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.
Lan T; Putta MR; Wang D; Dai M; Yu D; Kandimalla ER; Agrawal S
Biochem Biophys Res Commun; 2009 Aug; 386(3):443-8. PubMed ID: 19523922
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of novel human Toll-like receptor 8 agonists.
Kokatla HP; Sil D; Tanji H; Ohto U; Malladi SS; Fox LM; Shimizu T; David SA
ChemMedChem; 2014 Apr; 9(4):719-23. PubMed ID: 24474703
[TBL] [Abstract][Full Text] [Related]
19. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.
Levy O; Suter EE; Miller RL; Wessels MR
Blood; 2006 Aug; 108(4):1284-90. PubMed ID: 16638933
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8.
Lan T; Kandimalla ER
Methods Mol Biol; 2011; 764():249-61. PubMed ID: 21748646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
